Merck KGaA is open to more acquisitions, but not for its CDMO unitnews2025-10-16T15:18:38+00:00October 16th, 2025|Endpoints News|
Praxis reports double wins in Phase 3 essential tremor trials, sending stock upnews2025-10-16T15:14:10+00:00October 16th, 2025|Endpoints News|
Are PD-1xVEGF bispecifics being tested in the wrong kinds of cancer?news2025-10-16T14:47:42+00:00October 16th, 2025|Endpoints News|
Dianthus inks licensing deal with Chinese biotech; C4 targets $125M offeringnews2025-10-16T14:32:04+00:00October 16th, 2025|Endpoints News|
How wearable maker Whoop is making its move into healthcare news2025-10-16T14:30:34+00:00October 16th, 2025|Endpoints News|
AstraZeneca opens $445M expansion of Lokelma factory; Avidity Bio delays BLA for Duchenne drugnews2025-10-16T14:16:53+00:00October 16th, 2025|Endpoints News|
Town Hall Ventures raises $440M healthcare technology fundnews2025-10-16T13:30:57+00:00October 16th, 2025|Endpoints News|
Novartis’ Fabhalta gets confirmatory late-stage trial win in kidney disease IgANnews2025-10-16T13:03:03+00:00October 16th, 2025|Endpoints News|
J&J says Darzalex, Tecvayli combo improves survival odds in multiple myelomanews2025-10-16T12:00:04+00:00October 16th, 2025|Endpoints News|
